查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942975

異丁基亞硝酸鹽市場按產品類型、應用、最終用戶和分銷管道分類，全球預測（2026-2032年）

Isobutyl Nitrite Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年異丁基亞硝酸酯市值為 1.5932 億美元，預計到 2026 年將成長至 1.7294 億美元，年複合成長率為 7.89%，到 2032 年將達到 2.7116 億美元。

主要市場統計數據
基準年 2025 1.5932億美元
預計年份：2026年 1.7294億美元
預測年份：2032年 2.7116億美元
複合年成長率 (%) 7.89%

為異丁基亞硝酸酯在工業應用、監管壓力和戰略供應鏈考量中的當前作用提供了一個清晰權威的框架。

本執行摘要總結了構成亞硝酸異丁酯現況的複雜跨學科考量。引言部分概述了該化合物在工業和實驗室中的多種用途、影響其生產、分銷和使用的複雜監管環境，以及供應鏈和消費行為的交織動態。這為採購合規和策略團隊在不斷變化的環境中尋求清晰的分析奠定了基礎。

製造技術的創新、管理體制的收緊以及數位化供應鏈正在從根本上重塑生產、分銷和終端用戶趨勢。

異丁基亞硝酸酯市場正經歷多重變革，其生產、分銷和與終端用戶的互動方式都在重塑。生產製程控制的進步和更純淨合成路線的建立，拓展了產品品質的選擇範圍，並促進了工業級、醫藥級和試劑級產品之間的清晰區分。同時，多個司法管轄區日益嚴格的法規結構迫使生產商和經銷商加強整個供應鏈的合規流程和可追溯性。

探討關稅變化對異丁基亞硝酸鹽相關人員在採購合規和物流方面面臨的營運和策略影響

2025年美國政策的變化給異丁基亞硝酸酯的生產商、進口商和下游用戶帶來了新的挑戰。關稅調整及相關貿易措施迫使相關人員重新評估籌資策略和路線選擇，以在應對額外行政負擔的同時維持業務連續性。這些趨勢促使企業探索替代採購管道、近岸外包以及加強垂直整合，以降低貿易政策波動帶來的風險。

一個多層級細分框架，將產品等級、應用管道、最終用戶畫像和分銷管道連結起來，以揭示價值集中區域和合規風險。

詳細的市場區隔揭示了不同產品配方、用途、終端用戶類型和分銷管道的價值和風險集中。按產品類型分析，區分了工業級、醫藥級和試劑級產品，每種產品都有不同的品質規格、認證要求以及對各種下游製程的適用性。根據應用領域，需求分為工業用途、實驗室試劑用途、醫療用途和娛樂用途。娛樂用途市場進一步以消費者人口統計特徵（18-25歲、26-35歲及35歲以上）進行分析，以揭示不同年齡層消費者在購買行為和風險認知上的差異。

不同地區的監管差異、採購慣例和行業能力如何影響供應商策略和分銷模式？

區域趨勢對生產基地選擇、合規性和分銷策略具有決定性影響。在美洲，不同司法管轄區的監管執法和海關慣例差異顯著，迫使供應鏈管理者制定區域性合規應對措施和本地化分銷策略。該地區的監管對話和執法趨勢正在影響企業如何記錄原產地、認證純度以及管理敏感用途產品的監管鏈。

透過品質保證、合規計劃、數位化分銷以及製造商與經銷商之間的策略夥伴關係實現競爭差異化

異丁基亞硝酸酯市場的競爭格局呈現出多元化的格局，既有成熟的化學品製造商，也有專業供應商，還有靈活敏捷、以數位化為先的經銷商。主要企業透過投資品質保證、法規遵循計畫和可追溯性平台來脫穎而出，這些平台能夠證明所有權鍊和分析來源。製造商與授權經銷商之間的策略聯盟日益普遍，從而能夠提供捆綁式解決方案，以應對安全性和物流方面的複雜性。

採取實際措施加強可追溯性、實現採購多元化、使產品規格與最終用戶需求保持一致，並加強與經銷商的關係，以建立永續的韌性。

產業領導者應優先採取一系列切實有效、影響深遠的行動，以增強自身韌性、合規性和商業性地位。首先，應加強可追溯性和文件工作流程，以應對日益嚴格的監管詢問並簡化清關流程。實施標準化的分析證書、批次級追蹤和第三方檢驗，將有助於減少貿易摩擦，並支援下游安全應用。

我們嚴謹的三角調查方法結合了初步訪談、監管分析和交叉檢驗的綜合分析，以得出基於證據的、可操作的結論。

本調查方法融合了定性和定量方法，以確保對情況有全面、深入的理解。主要研究工作包括對採購主管、合規負責人、製造工程師、經銷商和實驗室經理進行結構化訪談，以收集有關供應鏈限制因素、品質要求和最終用戶行為的第一手資訊。這些訪談旨在揭示營運實務和策略重點，而非收集財務敏感資訊。

對業務重點、監管要求和策略選擇進行最終的綜合分析，這些因素決定了競爭優勢和供應鏈韌性。

這些結論提煉了對參與亞硝酸異丁酯生產、分銷和最終用途的相關人員而言最重要的啟示。在營運層面，更重視品質差異化、文件記錄和合規分銷將決定企業能否接觸到關鍵客戶群體以及能否跨多個司法管轄區企業發展。在策略層面，能夠使產品規格與製藥、實驗室和工業買家的嚴格要求保持一致的企業，將減少摩擦並創造具有競爭力的價值提案。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 異丁基亞硝酸鹽市場依產品類型分類

  • 工業級
  • 醫藥級
  • 試劑級

9. 異丁基亞硝酸鹽市場按應用領域分類

  • 工業的
  • 實驗室試劑
  • 醫療用途
  • 休閒用途

第10章 亞硝酸異丁酯市場（以最終用戶分類）

  • 化學製造
  • 消費者市場
  • 醫療設施
  • 研究所

第11章 異丁基亞硝酸鹽市場按分銷管道分類

  • 化學品經銷商
    • 零售經銷商
    • 經銷商
  • 線上
  • 藥局
    • 醫院藥房
    • 零售藥房

第12章 異丁基亞硝酸鹽市場區域分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 亞硝酸異丁酯市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國異丁基亞硝酸鹽市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國異丁基亞硝酸酯市場

第16章：中國亞硝酸異丁酯市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accela ChemBio Inc.
  • Avantor, Inc.
  • Brenntag SE
  • Cayman Chemical Company
  • Focus Chemicals Ltd
  • Merck KGaA
  • Otto Chemi Pvt. Ltd.
  • Spectrum Chemical Manufacturing Corp.
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • Univar Solutions Inc.
  • Vizag Chemi Pvt. Ltd.
Product Code: MRR-F847BD9C7158

The Isobutyl Nitrite Market was valued at USD 159.32 million in 2025 and is projected to grow to USD 172.94 million in 2026, with a CAGR of 7.89%, reaching USD 271.16 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 159.32 million
Estimated Year [2026] USD 172.94 million
Forecast Year [2032] USD 271.16 million
CAGR (%) 7.89%

A clear and authoritative framing of isobutyl nitrite's current role across industrial applications, regulatory pressures, and strategic supply chain considerations

The executive summary synthesizes the complex, cross-disciplinary considerations that define the current landscape for isobutyl nitrite. This introduction frames the compound's diverse industrial and laboratory roles, the nuanced regulatory context affecting its manufacture, distribution, and use, and the intersecting dynamics of supply chains and consumer behavior. It positions the ensuing analysis to inform procurement, compliance, and strategy teams seeking clarity in an evolving environment.

Contextualizing the substance across product quality distinctions, end-user needs, and distribution pathways helps to surface the levers that organizations must manage to maintain continuity and regulatory alignment. The introduction also clarifies the scope of the study: a structured review of product categories, application profiles, end-user segmentation, and distribution channels tied to regional regulatory and commercial realities. By establishing these parameters up front, the report guides readers toward the most consequential insights and strategic decisions, while highlighting the operational trade-offs that arise under shifting policy and market conditions.

How manufacturing innovations, tightening regulatory regimes, and digitalized supply chains are fundamentally reshaping production, distribution, and end-user dynamics

The landscape for isobutyl nitrite is undergoing several transformative shifts that are reshaping production, distribution, and end-user engagement. Advances in manufacturing process controls and purer synthesis routes are elevating product quality options and creating clearer differentiation between industrial grade, pharmaceutical grade, and reagent grade variants. At the same time, regulatory frameworks are tightening in multiple jurisdictions, prompting manufacturers and distributors to reinforce compliance protocols and traceability across the supply chain.

Concurrently, evolving consumption patterns are altering application mixes. Laboratory and medical demand is increasingly driven by precision and provenance, while other channels reflect a more fragmented set of drivers that include convenience, cost, and perceived safety. Digital channels are accelerating procurement workflows, integrating supplier verification and expedited logistics, and enabling new entrants to access specialized end users. These shifts are compelling legacy players to invest in quality assurance, supply-chain digitization, and targeted stakeholder engagement to preserve market access and reduce trade friction. As a result, competitive advantage is migrating toward organizations that can couple compliant production practices with nimble, data-driven distribution capabilities.

Navigating the operational and strategic repercussions of tariff changes across sourcing, compliance, and logistics for isobutyl nitrite stakeholders

Policy changes in the United States in 2025 have added a new layer of complexity for manufacturers, importers, and downstream users of isobutyl nitrite. Tariff adjustments and related trade measures have prompted reassessments of sourcing strategies and routing decisions, as stakeholders seek to preserve continuity while managing added administrative burdens. These developments have incentivized firms to explore alternative sourcing, nearshoring, and greater vertical integration to mitigate exposure to trade-policy volatility.

Operationally, affected organizations have had to enhance customs documentation, expand compliance teams, and recalibrate supplier contracts to reflect new cost structures and lead-time uncertainties. The cumulative impact also extends to logistics planning, where carriers and third-party providers are being evaluated for their ability to deliver predictable transit and customs clearance services. In response, some enterprises are deepening collaborations with trusted suppliers to secure preferential handling and certification pathways, and are investing in scenario planning to quantify potential supply interruptions. Importantly, organizational resilience now hinges on the ability to align procurement, legal, and commercial functions to navigate the evolving tariff landscape while preserving product integrity and regulatory compliance.

A layered segmentation framework linking product grades, application pathways, end-user profiles, and distribution channels to reveal where value and compliance risks concentrate

Detailed segmentation illuminates where value and risk concentrate across product formulations, usage profiles, end-user types, and distribution avenues. Based on Product Type, the analysis distinguishes Industrial Grade, Pharmaceutical Grade, and Reagent Grade, each carrying distinct quality specifications, certification requirements, and suitability for different downstream processes. Based on Application, demand is categorized into Industrial Use, Laboratory Reagent, Medical Use, and Recreational Use; the Recreational Use segment is further examined through Consumer Demographic cohorts segmented into 18-25, 26-35, and Above 35, which reveal divergent purchasing behaviors and risk perceptions.

Based on End User, the study covers Chemical Manufacturing, Consumer Market, Healthcare Facilities, and Research Laboratories, with Research Laboratories further broken down by Organization Type into Government Labs, Private Research Institutes, and Universities to show how procurement policies and funding cycles shape sourcing preferences. Based on Distribution Channel, the work analyzes Chemical Distributors, Online, and Pharmacies; Chemical Distributors are further parsed into Retail Distributors and Wholesale Distributors, while Online pathways are evaluated by Platform Type-E-Commerce Platforms, Manufacturer Websites, and Third-Party Marketplaces-and Pharmacies are delineated into Hospital Pharmacies and Retail Pharmacies. This layered segmentation facilitates targeted recommendations by connecting product grades to application suitability, end-user procurement behaviors, and channel economics, thereby enabling stakeholders to prioritize investments and compliance efforts according to the most relevant demand drivers.

How regional regulatory diversity, procurement practices, and industrial capacity across major global regions are shaping supplier strategies and distribution models

Regional dynamics exert a decisive influence on production choices, regulatory compliance, and channel strategies. In the Americas, regulatory enforcement and customs practices vary substantially across jurisdictions, requiring supply chain managers to maintain differentiated compliance playbooks and localized distribution strategies. Regulatory dialogue and enforcement trends in this region are shaping how companies document provenance, certify purity, and manage controlled distribution for sensitive applications.

Europe, Middle East & Africa present a heterogeneous regulatory tapestry in which harmonization efforts coexist with country-specific controls; as a result, companies operating across this region must balance centralized quality systems with localized registration and reporting obligations. Differences in healthcare procurement and laboratory funding models further affect demand characteristics across these markets. Asia-Pacific is characterized by rapid industrialization, a dense manufacturing base, and an expanding domestic research ecosystem, which together create both sourcing opportunities and jurisdictional compliance challenges. Across these regions, strategic actors are prioritizing localized regulatory expertise, supply-chain diversification, and adaptive distribution models to manage cross-border friction while capturing region-specific demand for different product grades and applications.

Competitive differentiation driven by quality assurance, compliance programs, digital distribution, and strategic manufacturer-distributor partnerships

Competitive dynamics in the isobutyl nitrite landscape reflect a mix of legacy chemical producers, specialty suppliers, and agile digital-first distributors. Leading organizations are differentiating through investments in quality assurance, regulatory compliance programs, and traceability platforms that demonstrate chain-of-custody and analytical provenance. Strategic partnerships between manufacturers and certified distributors are becoming more common, enabling bundled offerings that address both safety and logistical complexity.

Innovative entrants are leveraging digital channels to provide transparent product information, expedited fulfillment, and targeted marketing to niche end users such as research institutes and specific healthcare facilities. At the same time, incumbent players are responding with upgraded capabilities in process control, third-party certification, and contractual frameworks that lock in long-term supply relationships. Across the competitive set, intellectual property around purification methods, documentation workflows, and compliance processes represents a growing source of differentiation. In sum, success now depends on blending operational excellence with regulatory foresight and channel-focused go-to-market strategies that align with customer procurement processes.

Actionable steps to strengthen traceability, diversify sourcing, align product specifications with end-user needs, and fortify distributor relationships for sustained resilience

Industry leaders should prioritize a set of pragmatic, high-impact actions to strengthen resilience, compliance, and commercial positioning. First, enhance traceability and documentation workflows to satisfy increasingly stringent regulatory inquiries and to facilitate smoother customs clearance. Implementing standardized certificates of analysis, batch-level tracking, and third-party verification will reduce transaction friction and support safe downstream use.

Second, diversify sourcing and logistics pathways to mitigate concentrated risk arising from policy shifts and supplier disruptions. Nearshoring, multi-sourcing, and contractual flexibility can provide critical breathing room during periods of tariff or regulatory uncertainty. Third, invest in targeted product differentiation: aligning product specifications with the needs of pharmaceutical, laboratory, and industrial end users improves fit and reduces the risk of misapplication. Fourth, strengthen distributor relationships and segment-specific go-to-market motions to ensure reliable channel performance, particularly where pharmacies and online platforms serve as important access points. Finally, proactively engage with regulators and standards bodies to shape pragmatic compliance regimes and to anticipate reporting expectations. Taken together, these steps create a more defensible position against regulatory volatility while opening incremental commercial opportunities.

A rigorous, triangulated methodology combining primary interviews, regulatory analysis, and cross-validated synthesis to ensure evidence-based, actionable conclusions

The research methodology integrates qualitative and quantitative approaches to ensure a robust, triangulated understanding of the landscape. Primary research included structured interviews with procurement leads, compliance officers, manufacturing technologists, distributors, and laboratory managers to capture firsthand perspectives on supply-chain constraints, quality requirements, and end-use behaviors. These interviews were designed to surface operational practices and strategic priorities rather than to collect proprietary financial disclosures.

Secondary research encompassed a systematic review of regulatory statutes, customs guidance, technical monographs, and publicly available industry literature to map the normative requirements and technical attributes that define product grades. Data synthesis applied a triangulation approach: cross-referencing interview insights with publicly available regulatory documents and supplier literature to validate themes and identify divergences. Throughout, methodological rigor emphasized transparency in source provenance, careful treatment of confidential interview material, and sensitivity to jurisdictional variation. The result is an evidence-based narrative that links operational realities to regulatory obligations and commercial strategy without relying on single-source conclusions.

Concluding synthesis of operational priorities, regulatory imperatives, and strategic choices that will define competitive advantage and supply-chain resilience

The conclusion distills the most consequential implications for stakeholders engaged with isobutyl nitrite across production, distribution, and end use. Operationally, a heightened focus on quality differentiation, documentation, and compliant distribution will determine access to critical customer segments and the ability to operate across jurisdictions. Strategically, firms that align product specifications with the precise requirements of pharmaceutical, laboratory, and industrial buyers will reduce friction and create defensible value propositions.

Moreover, resilience in the face of trade-policy shifts and regulatory tightening depends on integrated planning across procurement, legal, and commercial functions, paired with investments in traceability and supplier diversification. Finally, the competitive environment rewards organizations that combine manufacturing discipline with go-to-market sophistication-those that can demonstrate provenance, certify quality, and deliver reliably through the right channels will secure advantaged positions as regulatory scrutiny and buyer expectations continue to evolve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Isobutyl Nitrite Market, by Product Type

  • 8.1. Industrial Grade
  • 8.2. Pharmaceutical Grade
  • 8.3. Reagent Grade

9. Isobutyl Nitrite Market, by Application

  • 9.1. Industrial Use
  • 9.2. Laboratory Reagent
  • 9.3. Medical Use
  • 9.4. Recreational Use

10. Isobutyl Nitrite Market, by End User

  • 10.1. Chemical Manufacturing
  • 10.2. Consumer Market
  • 10.3. Healthcare Facilities
  • 10.4. Research Laboratories

11. Isobutyl Nitrite Market, by Distribution Channel

  • 11.1. Chemical Distributors
    • 11.1.1. Retail Distributors
    • 11.1.2. Wholesale Distributors
  • 11.2. Online
  • 11.3. Pharmacies
    • 11.3.1. Hospital Pharmacies
    • 11.3.2. Retail Pharmacies

12. Isobutyl Nitrite Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Isobutyl Nitrite Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Isobutyl Nitrite Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Isobutyl Nitrite Market

16. China Isobutyl Nitrite Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Accela ChemBio Inc.
  • 17.6. Avantor, Inc.
  • 17.7. Brenntag SE
  • 17.8. Cayman Chemical Company
  • 17.9. Focus Chemicals Ltd
  • 17.10. Merck KGaA
  • 17.11. Otto Chemi Pvt. Ltd.
  • 17.12. Spectrum Chemical Manufacturing Corp.
  • 17.13. Thermo Fisher Scientific Inc.
  • 17.14. Tokyo Chemical Industry Co., Ltd.
  • 17.15. Univar Solutions Inc.
  • 17.16. Vizag Chemi Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ISOBUTYL NITRITE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ISOBUTYL NITRITE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ISOBUTYL NITRITE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ISOBUTYL NITRITE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ISOBUTYL NITRITE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY INDUSTRIAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY INDUSTRIAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY INDUSTRIAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY REAGENT GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY REAGENT GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY REAGENT GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY INDUSTRIAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY INDUSTRIAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY INDUSTRIAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY LABORATORY REAGENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY LABORATORY REAGENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY LABORATORY REAGENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY MEDICAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY MEDICAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY MEDICAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RECREATIONAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RECREATIONAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RECREATIONAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CONSUMER MARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CONSUMER MARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CONSUMER MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY HEALTHCARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY HEALTHCARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RETAIL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RETAIL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RETAIL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 127. GCC ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. GCC ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GCC ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. GCC ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 133. GCC ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 148. G7 ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. G7 ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. G7 ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. G7 ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 154. G7 ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 155. NATO ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. NATO ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. NATO ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. NATO ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 161. NATO ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL ISOBUTYL NITRITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA ISOBUTYL NITRITE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA ISOBUTYL NITRITE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA ISOBUTYL NITRITE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA ISOBUTYL NITRITE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA ISOBUTYL NITRITE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA ISOBUTYL NITRITE MARKET SIZE, BY CHEMICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA ISOBUTYL NITRITE MARKET SIZE, BY PHARMACIES, 2018-2032 (USD MILLION)